Kinga Matula
QurieGen is a TechBio company focused on transforming drug discovery through AI-powered virtual cell models and single-cell multi-omics technology. They address the fundamental failures of current drug development by opening the 'black box' of human biology using high-throughput single-cell multi-omic platforms combined with a lab-in-the-loop AI feedback system. Their approach enables predictive, biology-driven drug development by capturing multi-dimensional molecular data at the individual cell level, replacing trial-and-error methods with mechanistic insight and in silico validation.
